AstraZeneca takes next steps towards broad and equitable access to Oxford University’s COVID-19 vaccine
Agreements with CEPI and Gavi and the Serum Institute of India will bring vaccine to low and middle-income countries and beyond Global supply capacity to exceed two billion dosesAstraZeneca has taken the next steps in its commitment to broad and equitable global access to the University of Oxford’s COVID-19 vaccine, following landmark agreements with the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi the Vaccine Alliance, and the Serum Institute of India (SII). The Company today reached a $750m agreement with CEPI and Gavi to support the manufacturing, procurement and